Trials / Recruiting
RecruitingNCT07399028
A Study to Characterize Human Skin Changes From Biostimulator Treatments Via Non-invasive Imaging
A Single-center, Open-label Study to Characterize Human Skin Changes From Biostimulator Treatments Via Non-invasive Imaging
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 25 (estimated)
- Sponsor
- Galderma R&D · Industry
- Sex
- Female
- Age
- 45 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Adult subjects with moderate-to-severe cheek wrinkles will be treated with Sculptra for correction of fine lines and wrinkles in the cheek area.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Sculptra® | Sculptra injection will be performed to the cheeks using 25 G needle size. Injections will be performed subdermally, i.e., in the subcutaneous and supraperiosteal region. A maximum of 18 mL (2 vials) of Sculptra will be administered per treatment session with a maximum of 9 mL (1 vial) per cheek, evenly distributed within the treatment area. |
Timeline
- Start date
- 2025-10-21
- Primary completion
- 2026-09-01
- Completion
- 2026-09-01
- First posted
- 2026-02-10
- Last updated
- 2026-02-10
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT07399028. Inclusion in this directory is not an endorsement.